A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus

Kim Steegen1, Michelle Bronze, Elke Van Craenenbroeck

  • 1Department of Infectious Disease and Biomarkers, Tibotec-Virco Virology BVBA, Beerse, Belgium. ksteegen@its.jnj.com

AIDS Research and Therapy
|October 19, 2010
PubMed
Summary

Simplified HIV drug resistance testing using short reverse transcriptase sequences is reliable for resource-limited settings. This cost-effective approach aids in monitoring antiretroviral treatment effectiveness.